Biotechs: ESG, a future booster for the sector?
Although ESG has often been pushed to the background in the biotechnology sector, the trend could now be reversed. A formalisation of CSR policies and an emergence of initiatives to facilitate access to healthcare are taking shape at sector players. In our sample, MedinCell holds the figurehead position, bolstered by its innovative technology and controlled management of material challenges. Valneva (position on access to healthcare for LMICs) and Genfit (management of human capi...
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.